Zhenbo Zhang

Zhenbo Zhang

Auto-generated profile, based on publicly available information

Zhenbo Zhang

Department of Biochemistry, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, PR 00936-5067, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
EGEric Gracey
Eric Gracey
ZQZoya Qaiyum
Zoya Qaiyum
IAIbrahim Almaghlouth
Ibrahim Almaghlouth
DLDaeria Lawson
Daeria Lawson
SKSusan Karki
Susan Karki
RIRobert Davies Inman
Robert Davies Inman
Objective Ankylosing spondylitis (AS) is a chronic inflammatory disease of unknown origin in which interleukin (IL) 17 has been genetically and therapeutically recognised as a key player. Identification of the cellular sources and inducers of IL-17 is crucial in our understanding of the drivers of inflammation in AS. Recently, mucosal-associated invariant T (MAIT) cells have been implicated in autoimmune diseases. Their gut origin, effector phenotype and expression of multiple AS-associated genes, such as IL7R and IL23R, makes them potential contributors to the pathogenesis of AS. Methods Mononuclear cells from patients with AS, healthy controls (HCs) and patients with rheumatoid arthritis were isolated from blood and synovial fluid (SF). Flow cytometry was used to identify MAIT cells. Phenotype was assessed by intracellular staining for cytokines and granzyme. Function was assessed by antigen-specific stimulation using Salmonella, or antigen non-specific activation via priming with IL-7 or IL-23. Results MAIT cells were reduced in frequency in the blood of patients with AS compared with HCs, yet patients with AS had an elevated frequency IL-17A+ MAIT cells. There was an enrichment of MAIT cells in SF, which had an exaggerated IL-17 phenotype. IL-17 elevation in AS MAIT cells was dependent on priming with IL-7 but not IL-23 or antigen stimulation. The AS-associated IL7R single nucleotide polymorphism (SNP), rs11742270, had no effect on IL-7R expression or function in the experiments performed. Conclusions This study reveals a potential role for MAIT cells in patients with AS and is the first linking IL-7 to the elevated IL-17 profile in patients through the AS-associated risk gene IL7R.

9 January 2018 in Glycobiology
Verified
Journal Article
Open access
PDF file
JSJesus Emanauel Serrano-Negron
Jesus Emanauel Serrano-Negron
ZZZhenbo Zhang
Zhenbo Zhang
ARAndrea P Rivera-Ruiz
Andrea P Rivera-Ruiz
ABAditi Banerjee
Aditi Banerjee
EREva C Romero-Nutz
Eva C Romero-Nutz
DBDipak Banerjee
Dipak Banerjee
GRP78 (an Mr 78 kDa calcium dependent glucose binding protein) is located in ER lumen. It functions as ER chaperone and translocates proteins for glycosylation at the asparagine residue present in the sequon Asn-X-Ser/Thr. Paraffin sections from N-glycosylation inhibitor tunicamycin treated ER–/PR–/HER2+ (double negative) breast tumor in athymic nude mice exhibited reduced N-glycan but increased GRP78 expression. We have evaluated the effect of tunicamycin on cellular localization of GRP78 in metastatic human breast cancer cells MDA-MB-231 (ER–/PR–/HER2–). Tunicamycin inhibited cell proliferation in a time and dose-dependent manner. Nonmetastatic estrogen receptor positive (ER+) MCF-7 breast cancer cells were also equally effective. GRP78 expression (protein and mRNA) was higher in tunicamycin (1.0 μg/mL) treated MCF-7 and MDA-MB-231 cells. GRP78 is an ER stress marker, so we have followed its intracellular localization using immunofluorescence microscopy after subjecting the cancer cells to various stress conditions. Unfixed cells stained with either FITC-conjugated Concanavalin A (Con A) or Texas-red conjugated wheat germ agglutinin (WGA) exhibited surface expression of N-glycans but not GRP78. GRP78 became detectable only after a brief exposure of cells to ice-cold methanol. Western blotting did not detect GRP78 in conditioned media of cancer cells whereas it did for MMP-1. The conclusion, GRP78 is expressed neither on the outer-leaflet of the (ER–/PR–/HER2–) human breast cancer cells nor it is secreted into the culture media during tunicamycin-induced ER stress. Our study therefore suggests strongly that anti-tumorigenic action of tunicamycin can be modeled to develop next generation cancer therapy, i.e., glycotherapy for treating breast and other sold tumors.

14 June 2017 in Glycoconjugate Journal
Verified
Journal Article
Closed access
PDF file
DBDipak Banerjee
Dipak Banerjee
ZZZhenbo Zhang
Zhenbo Zhang
KBKrishna Baksi
Krishna Baksi
JSJesus Emanauel Serrano-Negron
Jesus Emanauel Serrano-Negron

28 December 2016 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
ZZZhenbo Zhang
Zhenbo Zhang
FCFrancesco Ciccia
Francesco Ciccia
FZFanxing Zeng
Fanxing Zeng
GGGiuliana Guggino
Giuliana Guggino
KYKirby Yee
Kirby Yee
NHNigil Haroon
Nigil Haroon
Objective: The basic mechanisms underlying the pathogenesis of ankylosing spondylitis (AS) remain unresolved. We previously reported an association of the single‐nucleotide polymorphism (SNP) rs2549782 in the endoplasmic reticulum aminopeptidase 2 gene (ERAP2) with AS. It is known that patients homozygous for the G allele (GG) of another ERAP2 SNP, rs2248374, lack expression of ERAP2 (ERAP2 null). The present study utilized this information to study the impact of ERAP2 deficiency on HLA–B27 expression in patients with AS, specifically focusing on the functional interaction of ERAP2 and HLA–B27 in peripheral blood mononuclear cells (PBMCs) from patients with AS and assessing the effects in vitro in specific cell lines.Methods: Expression of intact peptide HLA–B27 (pB27) or the major histocompatibility complex class I free heavy chains (FHCs) was assessed in PBMCs isolated from HLA–B27–positive patients with AS. ERAP2‐suppressed, stable B27–expressing C1R cells (C1R‐B27) were tested for the expression levels of pB27 and FHCs, as well as for markers of the unfolded protein response (UPR). Distribution of the ERAP2 SNPs rs2549782 and rs2248374 in patients with AS and in patients with Crohn's disease was assessed.Results: PBMCs from AS patients lacking ERAP2 expressed higher levels of FHCs than did PBMCs from patients positive for ERAP2. This finding was replicated in C1R‐B27 cells after suppression of ERAP2. In addition, ERAP2 suppression led to increased levels of the UPR markers BiP, CCAAT/enhancer binding protein homologous protein 10, and X‐box binding protein 1 [spliced] as compared to that in short hairpin RNA–treated control cells. There was strong linkage disequilibrium in the ERAP2 locus. All patients with the rs2549782 T allele (which reportedly increases the function of the ERAP‐2 protein) were homozygous for the G allele of rs2248374, leading to absence of ERAP2.Conclusion: ERAP2 deficiency causes increased FHC expression and up‐regulation of the UPR pathway.

9 December 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HAHumaira Adnan
Humaira Adnan
ZZZhenbo Zhang
Zhenbo Zhang
HPHyun-Joo Park
Hyun-Joo Park
CTChetankumar Tailor
Chetankumar Tailor
CCClare Che
Clare Che
CLClifford Lingwood
Clifford Lingwood
Many germ line diseases stem from a relatively minor disturbance in mutant protein endoplasmic reticulum (ER) 3D assembly. Chaperones are recruited which, on failure to correct folding, sort the mutant for retrotranslocation and cytosolic proteasomal degradation (ER-associated degradation-ERAD), to initiate/exacerbate deficiency-disease symptoms. Several bacterial (and plant) subunit toxins, retrograde transport to the ER after initial cell surface receptor binding/internalization. The A subunit has evolved to mimic a misfolded protein and hijack the ERAD membrane translocon (dislocon), to effect cytosolic access and cytopathology. We show such toxins compete for ERAD to rescue endogenous misfolded proteins. Cholera toxin or verotoxin (Shiga toxin) containing genetically inactivated (± an N-terminal polyleucine tail) A subunit can, within 2–4 hrs, temporarily increase F508delCFTR protein, the major cystic fibrosis (CF) mutant (5-10x), F508delCFTR Golgi maturation (<10x), cell surface expression (20x) and chloride transport (2x) in F508del CFTR transfected cells and patient-derived F508delCFTR bronchiolar epithelia, without apparent cytopathology. These toxoids also increase glucocerobrosidase (GCC) in N370SGCC Gaucher Disease fibroblasts (3x), another ERAD–exacerbated misfiling disease. We identify a new, potentially benign approach to the treatment of certain genetic protein misfolding diseases.

12 February 2009 in Glycoconjugate Journal
Verified
Journal Article
Closed access
PDF file
KBKrishna Baksi
Krishna Baksi
ZZZhenbo Zhang
Zhenbo Zhang
ABAditi Banerjee
Aditi Banerjee
DBDipak K. Banerjee
Dipak K. Banerjee